OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.030
+0.010 (0.50%)
At close: Jun 17, 2026, 4:00 PM EDT
2.040
+0.010 (0.49%)
After-hours: Jun 17, 2026, 4:45 PM EDT
OmniAb Market Cap
OmniAb has a market cap or net worth of $294.29 million as of June 17, 2026. Its market cap has increased by 75.59% in one year.
Market Cap
294.29M
Enterprise Value
264.89M
1-Year Change
75.59%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $294.29M, a decrease of -70.36%. That is a compound annual growth rate of -28.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 294.29M | 10.51% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enanta Pharmaceuticals | 346.03M |
| REGENXBIO | 344.31M |
| Lexeo Therapeutics | 343.14M |
| Upstream Bio | 331.96M |
| Neumora Therapeutics | 329.81M |
| Opus Genetics | 328.84M |
| Lineage Cell Therapeutics | 316.61M |
| Silence Therapeutics | 316.00M |